Renalytix Historical Cash Flow
| RNLX Stock | USD 0.16 0.01 6.67% |
Analysis of Renalytix cash flow over time is an excellent tool to project Renalytix AI future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Change To Operating Activities of 6.3 M or Total Cash From Financing Activities of 9.7 M as it is a great indicator of Renalytix ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Renalytix AI latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Renalytix AI is a good buy for the upcoming year.
Renalytix |
About Renalytix Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Renalytix balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Renalytix's non-liquid assets can be easily converted into cash.
Renalytix Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Most accounts from Renalytix's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Renalytix AI current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Renalytix AI. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. At this time, Renalytix's Change To Inventory is fairly stable compared to the past year. Change To Account Receivables is likely to rise to about 56.7 K in 2024, whereas Investments are likely to drop (4.2 K) in 2024.
Renalytix cash flow statement Correlations
Click cells to compare fundamentals
Renalytix Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Renalytix cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Investments | (849K) | 1M | (662K) | (370K) | (4K) | (4.2K) | |
| Change In Cash | 6.0M | 51.9M | (23.8M) | (16.7M) | (20.0M) | (19.0M) | |
| Total Cashflows From Investing Activities | (9.8M) | (849K) | (751K) | (662K) | (761.3K) | (799.4K) | |
| Other Cashflows From Financing Activities | 427K | 1K | (1.6M) | (991K) | (1.7M) | (1.6M) | |
| Depreciation | (485K) | 2.1M | 2.6M | 2.5M | 364K | 345.8K | |
| Capital Expenditures | 1.3M | 1.6M | 694K | 0.0 | 4K | 3.8K | |
| Total Cash From Operating Activities | (10.1M) | (24.6M) | (45.7M) | (32.7M) | (30.1M) | (31.6M) | |
| Change To Operating Activities | (4.2M) | 3.3M | (1.9M) | 5.2M | 6.0M | 6.3M | |
| Net Income | (10.6M) | (35.8M) | (49.6M) | (46.2M) | (33.5M) | (35.1M) | |
| Total Cash From Financing Activities | 16.5M | 77.2M | 25.5M | 15.1M | 10.3M | 9.7M | |
| End Period Cash Flow | 13.3M | 65.2M | 41.3M | 24.7M | 4.7M | 4.4M | |
| Change To Netincome | 399K | 2.4M | (945K) | 5.3M | 4.7M | 5.7M | |
| Change To Liabilities | 566.3K | 2.1M | 904K | 402K | 462.3K | 439.2K | |
| Stock Based Compensation | 1.2M | 2.2M | 4.6M | 2.9M | 1.7M | 2.4M | |
| Free Cash Flow | (11.4M) | (26.3M) | (46.4M) | (32.7M) | (30.1M) | (31.6M) | |
| Change In Working Capital | (662K) | 3.6M | 16K | 6.2M | (3.5M) | (3.4M) | |
| Begin Period Cash Flow | 7.3M | 13.3M | 65.2M | 41.3M | 24.7M | 27.8M | |
| Other Non Cash Items | 873K | (495K) | (5.8M) | (55K) | 3.6M | 4.5M | |
| Issuance Of Capital Stock | 16.7M | 77.2M | 9.2M | 19.6M | 13.6M | 21.7M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Renalytix Stock Analysis
When running Renalytix's price analysis, check to measure Renalytix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Renalytix is operating at the current time. Most of Renalytix's value examination focuses on studying past and present price action to predict the probability of Renalytix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Renalytix's price. Additionally, you may evaluate how the addition of Renalytix to your portfolios can decrease your overall portfolio volatility.